Covid inquiry: Bereaved daughters want lessons learned
Campaigners said they were not satisfied with Boris Johnson’s answers at the Covid inquiry.
Similar Posts
Covid inquiry: What is it investigating and how does it work?
The second round of public hearings examined how ministers made decisions during the pandemic.
Reckitt Benckiser unit recalls possibly contaminated baby formula powder, FDA says
Reckitt/Mead Johnson Nutrition has voluntarily recalled certain Nutramigen Hypoallergenic Infant Formula Powder products due to possible Cronobacter sakazakii contamination. Courtesy: Reckitt/Mead Johnson Baby formula maker Reckitt Benckiser’s Mead Johnson Nutrition has voluntarily chosen to recall certain batches of baby formula powder due to possible bacterial contamination, according to the U.S. Food and Drug Administration. The…
Playing a musical instrument good for brain health in later life – study
“Because we have such sensitive brain tests for this study, we are able to look at individual aspects of the brain function, such as short-term memory, long-term memory, and problem-solving and how engaging music effects that,” lead author Prof Anne Corbett told the BBC.
Safety plea over co-sleeping baby deaths figures
She added: “It is my sincere hope that by drawing attention to our concerns, prompted by the outcome of our investigations, that the number of baby deaths in which co-sleeping was a preventable factor, can be even further reduced through open conversations about safer sleeping.”
Scabies outbreak in UK linked to drug shortages, experts confirm: ‘Progressively worse’
Read this article for free! Plus get unlimited access to thousands of articles, videos and more with your free account! Please enter a valid email address. By entering your email, you are agreeing to Fox News Terms of Service and Privacy Policy, which includes our Notice of Financial Incentive. To access the content, check your…
Citi and others are bullish on biotech, medtech and more
2023 wasn’t a good year for the health-care sector, but some investors expect it to make a comeback this year — highlighting biotech and medical tech as areas to watch. “Emerging from a poor capital raising environment in ’22-23, where early-stage biotech companies grappled to fund their Research and Development efforts amid rising interest rates,…